Evidence map›Paper›PMID 39525552›Full record

ArticleCurrent breast cancer reports2022

Reproductive Considerations for Patients with Early-Onset Breast Cancer.

Versha Pleasant, Nicole Ulrich, Mark D Pearlman, Molly B Moravek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current breast cancer reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Gynecologic Care of Black Breast Cancer Survivors.Current breast cancer reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Versha PleasantCancer Genetics & Breast Health, Department of Obstetrics and Gynecology, University of Michigan, L4204 UH South, 1500 E. Medical Center Dr., SPC 5276, Ann Arbor, MI 48109-5276, USA.
Nicole UlrichAudobon Fertility, New Orleans, LA, USA.
Mark D PearlmanCancer Genetics & Breast Health, Department of Obstetrics and Gynecology, University of Michigan, L4204 UH South, 1500 E. Medical Center Dr., SPC 5276, Ann Arbor, MI 48109-5276, USA.
Molly B MoravekDivision of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Department of Urology, University of Michigan, Ann Arbor, MI, USA.

Funding

NIMHD NIH HHS L32 MD017779
6 · The paper itself

Abstract

Purpose of Review: Early-onset breast cancer presents various challenges in regard to reproductive health. This review examines the current data pertaining to issues such as fertility preservation, preimplantation genetics, the impact of chemotherapy and endocrine therapy, contraception, and pregnancy in the young breast cancer population. Recent Findings: Many breast cancer treatments such as chemotherapy and endocrine therapy can be gonadotoxic or teratogenic. Multiple fertility preservation options are now available to young breast cancer patients, including embryo and oocyte preservation, ovarian tissue preservation, and ovarian suppression with GnRH agonists. In patients with known cancer germline mutations, preimplantation genetic testing is an option. Summary: Fertility preservation and other reproductive services are expanding and offer great promise to the early-onset breast cancer community. Providers must be knowledgeable about the various options in order to better empower patients.

Indexed as

Early-onset breast cancerFertility preservationGenetic testingPreimplantation genetic testing

Identifiers

PMID39525552
PMCPMC11548833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.